Jurisprudence Exam Drug Schedules

Jurisprudence Exam Drug Schedules

DRUG SCHEDULES REGULATION CHANGES ? NOVEMBER 2021

The following amendments to the Schedules to the Drug Schedules Regulation made under the Pharmacy Operations and Drug Scheduling Act came into force, or will come into force, on the date indicated below. The amendments may not yet be reflected on the Drug Schedules Regulation published by the British Columbia government on the BC Laws website ().

OLD ENTRY

NEW ENTRY

IN FORCE DATE

None

2 Acetaminophen and ibuprofen, when sold in oral,

November 23, 2021

fixed-dose combinations, in package sizes containing

either more than 20 000 mg of acetaminophen or

more than 6 000 mg of ibuprofen

None

3 Acetaminophen and ibuprofen, when sold in oral,

November 23, 2021

fixed-dose combinations, in package sizes containing

20 000 mg or less of acetaminophen and 6 000 mg or

less of ibuprofen

None

1 Alpha-hydroxy acids, including but not limited to citric November 23, 2021

acid, glycolic acid, lactic acid, malic acid, mandelic

acid, ammonium glycolate, glycolic acid + ammonium

glycolate, alpha-hydroxyethanoic acid + ammonium

alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid,

alpha-hydroxycaprylic acid, hydroxycaprylic acid,

mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit

acids, alpha-hydroxy and botanical complex, l-alpha

hydroxy acid, glycomer in cross-linked fatty acids

alpha nutrium, when sold in topical formulations

containing alpha-hydroxy acids alone or in

combination at concentrations greater than 30%

and/or with a pH lower than 3.0, except when sold to

be applied to warts, corns or calluses

2 Fluticasone propionate when sold for the treatment of 2 Fluticasone propionate, when sold for the treatment of November 23, 2021

allergic rhinitis in a nasal spray that delivers 50 mcg

allergic rhinitis in a nasal spray that delivers 50 mcg

per metered spray, for individuals 18 years of age

per metered spray, for individuals 18 years of age and

and older and in package sizes containing more than

older and in package sizes containing more than 360

120 metered sprays

metered sprays

1022-Drug_Schedules_Regulation_Change_Nov2021 v2021.2 (Effective 2021-11-23)

OLD ENTRY

NEW ENTRY

IN FORCE DATE

3 Fluticasone propionate when sold for the treatment of 3 Fluticasone propionate, when sold for the treatment of November 23, 2021

allergic rhinitis in a nasal spray that delivers 50 mcg

allergic rhinitis in a nasal spray that delivers 50 mcg

per metered spray, for individuals 18 years of age

per metered spray, for individuals 18 years of age and

and older and in package sizes containing no more

older and in package sizes containing no more than

than 120 metered sprays

360 metered sprays

2 Hydroquinone (topical preparations)

1 Hydroquinone or its derivatives, when sold in a

November 23, 2021

concentration greater than 2% in preparations for

topical use on the skin

2 Hydroquinone or its derivatives, when sold in a

November 23, 2021

concentration less than or equal to 2% in preparations

for topical use on the skin

None

1 Mometasone furoate for the treatment of allergic

November 23, 2021

rhinitis in a nasal spray that delivers 50 mcg per spray

for those 12 years of age and older

1 Vitamin D in oral dosage form containing more than 1 Vitamin D in oral dosage form containing more than November 23, 2021

1 000 International Units of Vitamin D per dosage

62.5 mcg or 2 500 International Units of Vitamin D per

form or, where the largest recommended daily

dosage form or, where the largest recommended daily

dosage shown on the label would, if consumed by a

dosage shown on the label would, if consumed by a

person, result in the daily intake by that person of

person, result in the daily intake by that person of

more than 1 000 International Units of Vitamin D

more than 62.5 mcg or 2 500 International Units of

Vitamin D

3 Aloe vera latex, its extracts and derivatives (except

None

November 23, 2021

aloin) (dosage forms for systemic use containing

more than 300 mg per dosage unit)

3 Aluminum oxide

None

November 23, 2021

3 Belladonna alkaloids, their salts and derivatives for

None

November 23, 2021

topical use

3 Benzocaine and its salts (for topical use on mucous

None

November 23, 2021

membranes for teething)

3 Berberis vulgaris (Barberry)

None

November 23, 2021

3 Casanthranol

None

November 23, 2021

3 Deoxycholic acid and its salts (except when used in

None

November 23, 2021

an injectable form)

3 Electrolyte solutions (for oral rehydration)

None

November 23, 2021

3 Fluoride and its salts (oral preparations containing 1

None

November 23, 2021

mg or less of fluoride ion per dosage unit)

3 Heparin and its salts (for topical use)

None

November 23, 2021

2

1022-Drug_Schedules_Regulation_Change_Nov2021 v2021.2 (Effective 2021-11-23)

OLD ENTRY

3 Hydrocortisone or hydrocortisone acetate (when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin, for adults and children 2 years of age and over, and in package sizes containing no more than 30 g)

3 Iodine and its salts and derivatives (for topical use) 3 Lactic acid (preparations in concentrations of more

than 10%) 3 Magnesium citrate (cathartics) 3 Magnesium salicylate (except oral dosage forms

which also contain choline salicylate) 3 Narcotine and its salts (Noscapine) 3 Noscapine 3 Povidone - iodine (topical preparations, except in

concentrations of 5% or less) 3 Sodium biphosphate (cathartic) 3 Sodium phosphate (cathartics)

None

None None None None None None None None None

NEW ENTRY

IN FORCE DATE

November 23, 2021

November 23, 2021 November 23, 2021

November 23, 2021 November 23, 2021

November 23, 2021 November 23, 2021 November 23, 2021

November 23, 2021 November 23, 2021

3

1022-Drug_Schedules_Regulation_Change_Nov2021 v2021.2 (Effective 2021-11-23)

Drug Schedules Regulation

1 Abacavir and its salts 1 Abatacept 1 Abciximab 1 Acamprosate and its salts 1 Acarbose and its derivatives 1 Acebutolol and its salts 1 Acepromazine and its saltsV 1 Acetaminophen, when recommended for administration by intravenous injection 3 Acetaminophen (in sustained-release formulations containing greater than 650 mg per unit

or in package sizes greater than 50 units) 1 AcetanilideV 2 Acetarsol 1 Acetazolamide 1 Acetohexamide 1 Acetylcarbromal 1 Acetylcholine Chloride 2 Acetylcysteine 1 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage

unit in containers with more than 24 dosage units per container) 2 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage

unit in child-resistant containers with 24 or less dosage units per container or rectal preparations containing 150 mg or less per dosage unit) 3 Acetylsalicylic acid and its salts (in products intended for oral use by adults in strengths of 81 mg per dosage unit and 650 mg or greater per dosage unit and in rectal preparations containing more than 150 mg per dosage unit) 1 Acitretin and its salts and derivatives 1 Aconiazide and its salts

Printed: January 4, 2022 Current to January 6, 2020

1 of 64

Drug Schedules Regulation

1 Acyclovir and its salts

1 Adalimumab

1 Adapalene and its salts and derivatives

1 Adefovir and its salts and derivatives

1 Adenosine or its salts when sold or recommended for administration by intravenous injection

2 Adiphene and its salts for parenteral use

1 Adrenocortical hormones and their salts and derivativesV, including but not limited to betamethasone dipropionate, betamethasone phosphate, betamethasone sodium, betamethasone valerate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone acetate, dexamethasone phosphate, dexamethasone sodium, difluprednate, fludrocortisone acetate, flunisolide, fluticasone furoate, fluticasone propionate, hydrocortisone aceponate, hydrocortisone acetate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone sodium, methylprednisolone succinate, mometasone furoate, prednisolone acetate, prednisolone phosphate, prednisolone sodium, prednisone, triamcinolone acetonide, triamcinolone hexacetonide (except (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin, (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other non-prescription medicinal ingredient that provides 1% or less hydrocortisone in preparations for topical use on the skin, (c) clobetasone butyrate, when sold in a concentration of 0.05% in cream preparations for topical use on the skin, (d) fluticasone propionate, when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per metered spray for individuals 18 years of age and older), (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg per spray for those 12 years of age and older, and (f) triamcinolone acetonide in a nasal spray that delivers 55 mcg per spray for adults and children 12 years of age and older

1 Agalsidase alfa

1 Alatrofloxacin and its salts and derivatives

1 Aldesleukin

1 Alefacept

Printed: January 4, 2022 Current to January 6, 2020

2 of 64

Drug Schedules Regulation

1 Alemtuzumab 1 Alendronic acid and its salts 1 Alfacalcidol 1A Alfentanil 1 Alfuzosin and its salts 1 Aliskiren and its salts 1 Alkyl nitrites 1 Allergy serums 2 Allethrins (pyrethrins) 1 Allopurinol 1 Allylisopropylacetylurea 1 Almotriptan and its salts 3 Aloe vera latex, its extracts and derivatives (except aloin) (dosage forms for systemic use

containing more than 300 mg per dosage unit) 1 Alpha-chloralose 1 Alphadolone and its salts 1 Alphaxalone 1 Alprazolam 1 Alteplase and its salts and derivatives 1 Altrenogest 1 Altretamine 3 Aluminum oxide 1 Alverine and its salts (for parenteral use) 1 Amantadine and its salts 1 Ambenonium chloride

Printed: January 4, 2022 Current to January 6, 2020

3 of 64

Drug Schedules Regulation

1 Ambrisentan 1 Amifostine and its salts 1 Amikacin and its salts and derivatives 1 Amiloride and its salts 1 4-Amino-pteroyl aspartic acid and its salts 1 Amino acid solutions (for parenteral use) 1 Aminocaproic acid 1 Aminoglutethimide 1 Aminolevulinic acid and its salts and derivatives 1 Aminophylline 1 Aminopromazine [proquamezine] and its salts 1 Aminopterin and its salts 1 Aminopyrine and its derivativesV 1 4-Aminosalicylic acid and its salts 1 5-Aminosalicylic acid 1 Amiodarone and its salts 1 Amitraz 1 Amitriptyline and its salts 1 Amlexanox and its salts and derivatives 1 Amlodipine and its salts 1 Ammonium bromide 1 Amobarbital 1 Amoxapine 1 Amoxicillin and its salts and derivatives

Printed: January 4, 2022 Current to January 6, 2020

4 of 64

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download